who medicines strategy - libdoc.who.int - World Health Organization

MEDICINES AND PUBLIC HEALTH | 23OBJECTIVES COMPONENTS EXPECTED OUTCOMES IN COUNTRIESQUALITY5ANDNorms and standards forSAFETYpharmaceuticalsGlobal norms, standard, and 5.3 Pharmaceutical specifications and reference materialsThe quality, safetydeveloped and maintainedguidelines for the quality, safety,and efficacy of alland efficacy of medicinesmedicines assured strengthened and promoted.by strengthening andputting into practiceregulatory and qualityassurance standardsRATIONALUSETherapeutically soundand cost-effective useof medicines by healthprofessionals andconsumers6Medicines regulation and qualityassurance systemsInstruments for effective drugregulation and quality assurancesystems promoted in order tostrengthen national drug regulatoryauthorities.7Rational use by health professionalsand consumersAwareness raising and guidance oncost-effective and rational use ofmedicines promoted, with a view toimproving medicines use by healthprofessionals and consumers.5.1 Pharmaceutical norms, standards, and guidelines developed orupdated5.2 Medicines nomenclatures and classification efforts continued5.4 Balance between abuse prevention and appropriate access topsychoactive substances achieved6.1 Medicines regulation effectively implemented and monitored6.2 Information management and exchange systems promoted6.3 Good practices in medicine regulation and quality assurancesystems promoted6.4 Post-marketing surveillance of medicine safety maintained andstrengthened6.5 Use of substandard and counterfeit medicines reduced6.6 Prequalification of products and manufacturers of medicinesfor priority diseases and quality control laboratories, asappropriate, through procedures and guidelines appropriate forthis activity6.7 Safety of new priority and neglected medicines enhanced6.8 Regulatory harmonization monitored and promoted, asappropriate, and networking initiatives developed7.1 Rational use of medicines by health professionals andconsumers advocated7.2 Essential medicines list, clinical guidelines, and formularyprocess developed and promoted7.3 Independent and reliable medicines information identifieddisseminated and promoted7.4 Responsible ethical medicines promotion for healthprofessionals and consumers encouraged7.5 Consumer education enhanced7.6 Drug and therapeutics committees promoted at institutional anddistrict/national levels7.7 Training in good prescribing and dispensing practices promoted7.8 Practical approaches to contain antimicrobial resistancedeveloped based on the WHO Global Strategy to containAntimicrobial Resistance7.9 Identification and promotion of cost-effective strategies topromote rational use of medicines